Thursday, October 30, 2025

Study reveals the role of geography in the opioid crisis



The findings point to state policies involving the presence of “pill mills” as influences on addiction over time.





Massachusetts Institute of Technology




-The U.S. opioid crisis has varied in severity across the country, leading to extended debate about how and why it has spread. 

Now, a study co-authored by MIT economists sheds new light on these dynamics, examining the role that geography has played in the crisis. The results show how state-level policies inadvertently contributed to the rise of opioid addiction, and how addiction itself is a central driver of the long-term problem. 

The research analyzes data about people who moved within the U.S., as a way of addressing a leading question about the crisis: How much of the problem is attributable to local factors, and to what extent do people have individual characteristics making them prone to opioid problems?

“We find a very large role for place-based factors, but that doesn’t mean there aren’t person-based factors as well,” says MIT economist Amy Finkelstein, co-author of a new paper detailing the study’s findings. “As is usual, it’s rare to find an extreme answer, either one or the other.”

In scrutinizing the role of geography, the scholars developed new insights about the spread of the crisis in relation to the dynamics of addiction. The study concludes that laws restricting pain clinics, or “pill mills,” where opioids were often prescribed, reduced risky opioid use by 5 percent over the 2006-2019 study period. Due to the path of addiction, enacting those laws near the onset of the crisis, in the 1990s, could have reduced risky use by 30 percent over that same time. 

“What we do find is that pill mill laws really matter,” says MIT PhD student Dean Li, a co-author of the paper. “The striking thing is that they mattered a lot, and a lot of the effect was through transitions into opioid addiction.” 

The paper, “What Drives Risky Prescription Opioid Use: Evidence from Migration,” appears in the Quarterly Journal of Economics. The authors are Finkelstein, who is the John and Jennie S. MacDonald Professor of Economics; Matthew Gentzkow, a professor of economics at Stanford University; and Li, a PhD student in MIT’s Department of Economics. 

The opioid crisis, as the scholars note in the paper, is one of the biggest U.S. health problems in recent memory. As of 2017, there were more than twice as many U.S. deaths from opioids as from homicide. There were also at least 10 times as many opioid deaths compared to the number of deaths from cocaine during the 1980s-era crack epidemic in the U.S. 

Many accounts and analyses of the crisis have converged on the increase in medically prescribed opioids starting in the 1990s as a crucial part of the problem; this was in turn a function of aggressive marketing by pharmaceutical companies, among other things. But explanations of the crisis beyond that have tended to fracture. Some analyses emphasize the personal characteristics of those who fall into opioid use, such as a past history of substance use, mental health conditions, age, and more. Other analyses focus on place-based factors, including the propensity of area medical providers to prescribe opioids. 

To conduct the study, the scholars examined data on prescription opioid use from adults in the Social Security Disability Insurance program from 2006 to 2019, covering about 3 million cases in all. They defined “risky” use as an average daily morphine-equivalent dose of more than 120 milligrams, which has been shown to increase drug dependence.

By studying people who move, the scholars were developing a kind of natural experiment — Finkelstein has also used this same method to examine questions about disparities in health care costs and longevity across the U.S. In this case, in focusing on the opioid consumption patterns of the same people as they lived in different places, the scholars can disentangle the extent to which place-based and personal factors drive usage. 

Overall, the study found a somewhat greater role for place-based factors than for personal characteristics in accounting for the drivers of risky opioid use. To see the magnitude of place-based effects, consider someone moving to a state with a 3.5 percentage point higher rate of risky use — akin to moving from the state with the 10th lowest rate of risky use to the state with the 10th highest rate. On average, that person’s probability of risky opioid use would increase by a full percentage point in the first year, then by 0.3 percentage points in each subsequent year.

Some of the study’s key findings involve the precise mechanisms at work beneath these top-line numbers.

In the research, the scholars examine what they call the “addiction channel,” in which opioid users fall into addiction, and the “availability channel,” in which the already-addicted find ways to sustain their use. Over the 2006-2019 period, they find, people falling into addiction through new prescriptions had an impact on overall opioid uptake that was 2.5 times as large as that of existing users getting continued access to prescribed opioids. 

When people who are not already risky users of opioids move to places with higher rates of risky opioid use, Finkelstein observes, “One thing you can see very clearly in the data is that in the addiction channel, there’s no immediate change in behavior, but gradually as they’re in this new place you see an increase in risky opioid use.” 

She adds: “This is consistent with a model where people move to a new place, have a back problem or car accident and go to a hospital, and if the doctor is more likely to prescribe opioids, there’s more of a risk they’re going to become addicted.”

By contrast, Finkelstein says, “If we look at people who are already risky users of opioids and they move to a new place with higher rates of risky opioid use, you see there’s an immediate increase in their opioid use, which suggests it’s just more available. And then you also see the gradual increase indicating more addiction.”

By looking at state-level policies, the researchers found this trend to be particularly pronounced in over a dozen states that lagged in enacting restrictions on pain clinics, or “pill mills,” where providers had more latitude to prescribe opioids. 

In this way the research does not just evaluate the impact of place versus personal characteristics; it quantifies the problem of addiction as an additional dimension of the issue. While many analyses have sought to explain why people first use opioids, the current study reinforces the importance of preventing the onset of addiction, especially because addicted users may later seek out nonprescription opioids, exacerbating the problem even further. 

“The persistence of addiction is a huge problem,” Li says. “Even after the role of prescription opioids has subsided, the opioid crisis persists. And we think this is related to the persistence of addiction. Once you have this set in, it’s so much harder to change, compared to stopping the onset of addiction in the first place.” 

Research support was provided by the National Institute on Aging, the Social Security Administration, and the Stanford Institute for Economic Policy Research.

###

Written by Peter Dizikes, MIT News

Paper: “What Drives Risky Prescription Opioid Use: Evidence from Migration”

https://academic.oup.com/qje/article-abstract/140/4/3133/8225753

U.S. Public not highly knowledgeable about safety of MMR vaccine or risks of getting measles






Public also unclear whether RFK Jr. supports MMR vaccination



Annenberg Public Policy Center of the University of Pennsylvania

Recommending the measles 

image: 

Annenberg Science and Public Health (ASAPH) Surveys Apr. 2022 - Aug. 2025

view more 

Credit: Annenberg Public Policy Center






Nearly 1,650 cases of measles in 42 states have been confirmed this year in the United States by the Centers for Disease Control and Prevention (CDC), the largest annual number in 34 years. This includes a fresh outbreak of over a hundred people that began in late summer in Arizona and Utah. Public health experts such as Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, suspect the actual total could be higher.

The outbreaks come over two decades after measles was declared “eliminated” from the United States in 2000, a status that signifies the absence of “the continuous spread of the disease” for more than 12 months, the CDC says, thanks largely to a “highly effective vaccination program.”

After decades without many cases, however, and several years in which the safety of new Covid-19 vaccines and others have been called into question, an Annenberg health survey finds that the public is less informed than it should be of the dangers of measles – a highly contagious disease that can lead to death or disability – and less certain than it used to be of the value of vaccination.

The survey by the Annenberg Public Policy Center of the University of Pennsylvania shows that while most U.S. adults (82%) would recommend that eligible children in their household get the MMR vaccine, which protects against measles, mumps, and rubella, the percentage has declined significantly since November 2024 (90%). The survey also finds that:

  • The public is confused about whether the top U.S. health official, Health and Human Services Secretary Robert F. Kennedy Jr., recommends that children be vaccinated against measles;
  • Most Americans believe that vaccines like the MMR vaccine do not cause autism – but significantly fewer know this than in recent years;
  • Over half of those surveyed are not sure whether a mercury-based preservative in some vaccines affects a person’s chances of developing autism, when evidence has shown no link between the preservative and autism;
  • A quarter of the public thinks getting the measles is likely to be less deadly than it is.

“Mixed messages about the safety and efficacy of measles vaccination from those leading health agencies fuel confusion and cultivate a climate that is hospitable to an otherwise preventable and sometimes deadly disease,” said Kathleen Hall Jamieson, director of the Annenberg Public Policy Center (APPC).

The survey was conducted August 5-18, 2025, among nearly 1,700 U.S. adults on a nationally representative panel. See the end of this news release or the topline for additional details.

Views on the MMR vaccine

The survey finds that most American adults know

… What MMR prevents: Given the choice of a number of different diseases and conditions that begin with the letters “M” and “R,” around two-thirds of those surveyed know that the MMR vaccine is designed to prevent measles (68%), mumps (65%), and rubella (64%). As many or more people correctly did not select alternatives such as meningitis (66% did not select), mpox (68% did not select), rhinitis (69% did not select), menopause (70% did not select), and rigor mortis (70% did not select). However, more than 1 in 4 people (27%) overall say they are not sure what the MMR vaccine is designed to prevent.

… Vaccination is the best way to avoid getting measles: Given the options of vaccination, a healthy diet, or neither, a strong majority knows the best way to prevent getting measles is to be vaccinated (81%), while 1% say “eating a healthy diet,” 6% say neither, and 11% are not sure.

… The MMR provides lifetime protection against measles: Most people (67%) know it is true that the MMR vaccine usually protects people who receive it from getting measles for their entire lifetime, though 21% are not sure and 13% think this is false. The CDC says the MMR vaccine usually protects people for life against measles and rubella, though immunity against mumps may diminish over time.

Giving children the MMR vaccine

The CDC recommends that children get a first dose of the MMR vaccine at 12 to 15 months old and a second dose between ages 4 and 6 years old. The CDC says one dose is 93% effective at preventing measles and two doses are 97% effective.

Recommending MMR for a child: Although a large majority of people support giving children the vaccine, the number declined significantly in just over nine months. The August 2025 survey finds that 82% would recommend that an eligible child in their household get an MMR vaccine, compared with 90% in November 2024.

Why childhood measles is less common than a century ago: A majority (77%) knows that “the main reason” children in the United States are much less likely to get measles today than a century ago is effective vaccination, rather than better sewage treatment and water purification (4%) or better nutrition (2%), though 13% say they are not sure and 3% say “none of the above.”

Two doses: Less than half of those surveyed (42%) know children need two doses of the MMR vaccine for full protection from measles, mumps, and rubella, while 48% are not sure.

RFK Jr. and the measles vaccine

The American public is unclear about where Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., a longtime critic of vaccines, stands on the MMR vaccine. Less than a quarter of the public (23%) says that he recommends that children be vaccinated against measles, while 29% say he does not recommend it, and almost half of the public (48%) is not sure.

In January confirmation hearings for HHS secretary, Kennedy “refused to say that vaccines do not cause autism – despite a large body of evidence showing there is no link,” according to FactCheck.org, a project of the Annenberg Public Policy Center. In fact, Kennedy “also pointed to a flawed paper to suggest that there is credible evidence to claim vaccines cause the disorder.”

According to the CDC: “There is no link between the MMR vaccine and autism.”

As secretary, Kennedy has made misleading and unsupported claims about the MMR vaccine, the measles, and vaccination in general. He has downplayed the risks of measles and this year’s large measles outbreak in Texas. FactCheck.org has reviewed a number of his claims on various issues – see its articles.

Last spring, during the Texas outbreak, Kennedy did make positive statements about vaccination. On April 6, he wrote on X (formerly Twitter), “The most effective way to prevent the spread of measles is the MMR vaccine.” In an April 8 CBS interview, he said, “We encourage people to get the measles vaccine.” Yet Kennedy also said, “We don’t know the risks of many of these products because they’re not safety tested.”

As FactCheck.org writes, hours after his post on X, Kennedy praised two Texas physicians as “extraordinary healers” for using two unsupported treatments for measles. On March 2, Kennedy wrote on Fox News that vaccines “not only protect individual children from measles, but also contribute to community immunity…” But as FactCheck.org also notes, he did not explicitly say the vaccine is safe, nor did he specifically advocate vaccination.

During the Texas outbreak, Kennedy suggested that poor nutrition and a lack of exercise play a role in measles and misleadingly focused on vitamin A, including from cod liver oil, as a treatment. Even so, nearly 4 in 5 Americans (79%) know it is true that “healthy, well-nourished children can get measles.” Just 7% think that is false and 14% are not sure.

CDC page dated January 17, 2025, (accessed Oct. 27) states: “The best way to protect against measles is to get the measles, mumps, and rubella (MMR) vaccine. Children may get the measles, mumps, rubella, and varicella (MMRV) vaccine instead, which protects against chickenpox too.”

Most see no link between vaccines and autism

No evidence vaccines cause autism: About two-thirds of the public (65%) say it is false to claim that vaccines given to children for diseases like measles, mumps, and rubella cause autism, though that represents a significant decrease from prior years (June 2021-July 2024), when 70-74% of the public agreed it was false to link autism with vaccines. In 2004, the National Academy of Medicine (then named the Institute of Medicine) determined that “the body of epidemiological evidence favors rejection of a causal relationship between the MMR vaccine and autism evidence.” The CDC, on a web page dated Dec. 20, 2024 (accessed Oct. 29), wrote that “studies have shown that there is no link between receiving vaccines and developing ASD” (autism spectrum disorder).

Vaccines are safe: A substantial majority of the public (70%) similarly says that vaccines approved for use in the United States are safe, though that also represents a decline from past years (April 2021-January 2022), when 76-79% said vaccines are safe.

No evidence of an autism-thimerosal link: Thimerosal, a mercury-based preservative used in some vaccines since the 1930s, has been the target of unfounded and misleading claims by anti-vaccine advocates, including claims that it is ineffective, a neurotoxin, and may be tied to autism. In its 2004 report, the National Academy of Medicine determined that evidence “favors rejection of a causal relationship between thimerosal-containing vaccines and autism.” Numerous studies since have also supported thimerosal’s safety, according to FactCheck.org. Thimerosal has not been in childhood vaccines other than flu vaccines since 2001. In July 2025, Kennedy signed off on recommendations by the CDC’s Advisory Committee on Immunization Practices to remove thimerosal from U.S. flu vaccines.

Asked about any connection between thimerosal and autism, half of those surveyed (51%) are not sure whether thimerosal increases, decreases, or has no effect on the chances that a person getting a vaccine will develop autism. Over a third (37%) correctly say it has no effect on the chances of developing autism, and 10% say it increases the chances.

  • To learn more about autism and the challenges it may pose for young people, see “If Your Adolescent Has Autism: An Essential Resource for Parents” (Oxford University Press, 2025), a new book in a series developed by the Adolescent Mental Health Initiative. The initiative is a joint project of the Annenberg Public Policy Center and The Annenberg Foundation Trust at Sunnylands under the guidance of Patrick E. Jamieson, director of APPC’s Annenberg Health and Risk Communication Institute. 

Knowing about the consequences of getting measles

Most Americans have little firsthand experience with measles, which, as noted above, was declared “eliminated” from the United States in 2000, according to the CDC. If current trends hold, however, “there would appear to be grounds for the U.S. to lose measles elimination status,” according to KFF researcher Josh Michaud. The survey finds that many Americans are unsure about the possible consequences of getting measles:

  • Only 22% correctly know that some people experience a swelling of the brain, known as encephalitis, as a result of having measles. A small number (3%) say you can get encephalitis from the measles vaccine, which is extraordinarily rare. Ten percent say you cannot get encephalitis from measles or the measles vaccine, 6% say you can get it from both, but most people (60%) are not sure.
  • Less than a third (30%) know that getting measles increases the chances of getting some serious illnesses later in life, while 24% say it has no effect on getting serious illnesses later, 8% say it decreases the chances, and 38% are not sure.
  • Most people are not sure how many children die as a result of getting measles (58%) – only 9% correctly know it is about 1 in 1,000, while a quarter of those surveyed (26%) chose lower rates, and 8% chose higher rates. This year’s U.S. outbreaks have so far resulted in three deaths, two of them children.
  • About 1 in 5 people (19%) believe that among children who get the MMR vaccine none are likely to die as a result. Half of those surveyed (50%) are not sure, and about a third (32%) chose higher rates. According to the Infectious Disease Society of America, “There have been no deaths shown to be related to the MMR vaccine in healthy people.” 

Annenberg Science and Public Health survey

The survey data come from the 25th wave of a nationally representative panel of 1,699 U.S. adults conducted for the Annenberg Public Policy Center by SSRS, an independent market research company. Most have been empaneled since April 2021. To account for attrition, replenishment samples have been added over time using a random probability sampling design. The most recent replenishment, in September 2024, added 360 respondents to the sample. Wave 25 of the Annenberg Science and Public Health (ASAPH) survey, fielded August 5-18, 2025, has a margin of sampling error (MOE) of ± 3.5 percentage points at the 95% confidence level.

Download the topline and the methods report.

The policy center has been tracking the American public’s knowledge, beliefs, and behaviors regarding vaccination, Covid-19, flu, RSV, and other consequential health issues through this survey panel for more than four years. In addition to APPC Director Kathleen Hall Jamieson, APPC’s ASAPH survey team includes research analyst Laura A. Gibson, Patrick E. Jamieson, director of the Annenberg Health and Risk Communication Institute, and Ken Winneg, managing director of survey research.

See other recent Annenberg health survey news releases:

The Annenberg Public Policy Center was established in 1993 to educate the public and policy makers about communication’s role in advancing public understanding of political, science, and health issues at the local, state, and federal levels.


Where does RFK Jr. stand on the measles vaccine? 

Annenberg Science and Public Health (ASAPH) Survey Aug. 2025, N=1699, MOE=+/-3.5%

Annenberg Science and Public Health (ASAPH) Surveys Jun. 2021 - Aug. 2025

Credit